Co-Authors
This is a "connection" page, showing publications co-authored by Carlo Buonerba and Pellegrino Cerino.
Connection Strength
2.522
-
An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2. Future Sci OA. 2021 Sep; 7(8):FSO739.
Score: 0.951
-
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study. Future Sci OA. 2021 Jan 12; 7(4):FSO673.
Score: 0.924
-
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2. Front Public Health. 2021; 9:649781.
Score: 0.236
-
No detection of SARS-CoV-2 in animals exposed to infected keepers: results of a COVID-19 surveillance program. Future Sci OA. 2021 Aug; 7(7):FSO711.
Score: 0.235
-
The TNFRSF13C H159Y Variant Is Associated with Severe COVID-19: A Retrospective Study of 500 Patients from Southern Italy. Genes (Basel). 2021 06 08; 12(6).
Score: 0.059
-
Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19. Int J Mol Sci. 2021 May 20; 22(10).
Score: 0.059
-
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience. 2021 Apr 23; 24(4):102322.
Score: 0.058